Online demonstration tool showcases Adents Prodigi, a Cloud traceability solution that centrally manages pharmaceutical serialization. (Credit: Adents)
Adents, a provider of serialization and track and trace solutions, launched an online demonstration tool showcasing Adents Prodigi, a Cloud traceability solution that centrally manages pharmaceutical serialization regulatory requirements across a comprehensive set of production and supply chain scenarios.
The free tool, which can be accessed at www.adents-prodigi.com, amounts to a test drive of Adents’ Level 4 serialization solution. The demo tool provides both insight and transparency, adding tangibility to the complex, multi-faceted track and trace arena.
The demo tool works in an “if/then” setup. Users can build and add manufacturing facilities, “work” with hypothetical trading partners, add or subtract regulations and target markets, and explore other situational factors that showcase the Prodigi’s ability to handle an array of supply chain scenarios.
The demo also allows users to see how Prodigi ties unit levels to bundles and pallets per the industry standard parent-child relationship.
Adents Prodigi entered the market as the only Cloud traceability solution that can centrally manage regulatory requirements mandated in the pharmaceutical industry, connect multiple trading partners, and allow pharmaceutical companies and CMOs to benefit from the massive amounts of data generated during the serialization and track and trace process.
It also opens up new horizons beyond regulatory compliance, in terms of data analysis (including Microsoft Power BI), machine learning tools, or additional capabilities through existing in-house or third-party solutions.
Via Prodigi, Adents became the first European provider to offer a certified gateway to the European Medicines Verification System (EMVS). Having joined the pilot program, Adents is in the process of connecting Prodigi with the Russian Hub, and integration with Origin—a central data repository in the United States operated by the Healthcare Distribution Alliance (HDA)—is underway.
(Source: Adents)
